Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000180578 | SCV000233048 | benign | not specified | 2017-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000836089 | SCV000977919 | likely benign | not provided | 2021-06-09 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 30467950, 27535533, 26582918) |
Labcorp Genetics |
RCV000836089 | SCV001022450 | likely benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000836089 | SCV004159700 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | COL9A1: PP3, BS1 |
Mayo Clinic Laboratories, |
RCV000836089 | SCV004227283 | uncertain significance | not provided | 2023-01-13 | criteria provided, single submitter | clinical testing | BS1, PP3 |
Laboratory of Diagnostic Genome Analysis, |
RCV000836089 | SCV001799317 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000180578 | SCV001920430 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003917683 | SCV004730882 | benign | COL9A1-related disorder | 2019-07-09 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |